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Summary.-The anti-tumour activity induced by glucans (lentinan, yeast cell walls,
pseudonigeran, dextran, DEAE-dextran and dextran sulphate) and fructosans
(levan and carboxymethyl-levan) was compared with the activity of C.parvum. The
following effects on tumour systems in CBA mice were assayed: (a) adjuvant activity
on the immune response against tumour-specific transplantation antigens (TSTA)
with a methylcholanthrene-induced fibrosarcoma; (b) cytostatic activityofperitoneal
macrophages against radiation-induced leukaemia cells; and (c) inhibition oftumour
nodule formation in the lungs following i.v. injection of fibrosarcoma cells.
All the polysaccharides induced cytostatic macrophages, but the dextrans and
levans did so only after i.p. and not i.v. injection. Only lentinan, yeast cell walls and
pseudonigeran were active in the lung-nodule inhibition test; and only lentinan and
dextran sulphate showed slight adjuvant activity for TSTA.
It is concluded that the anti-tumour activity induced by these polysaccharides is
predominantly non-specific macrophage-mediated and much weaker thanthatfound
with C. parvum.
CORYNEBACTERIUMPARVUMis apotent
stimulant of the mononuclear phagocytic
system (MPS) and causes increases in
spleen and liver weight (Halpern et al.,
1964). Itis also animmunological adjuvant
(reviewed by Howard, Scott and Christie,
1973), and an inducer of anti-tumour
activity (reviewed by Scott, 1974a).
Variousglucosepolymers (glucans) share
one or more of the biological activities of
C. parvum (CP). Zymosan (yeast cell
walls) stimulates the MPS (Benacerraf
and Sebestyen, 1957), and increases resist-
ance to tumour growth (Manowski, Yama-
shita and Diller, 1957; Bradner, Clarke
and Stock, 1958). The active component
of zymosan as regards MPS stimulation
is a glucan (Riggi and Di Luzio, 1961).
Lentinan, another glucan offungal origin,
is an anti-tumour agent (Chihara et al.,
1969, 1970) and adjuvant (Dresser and
Phillips, 1974; Dennert and Tucker, 1973).
Dextran stimulates the MPS (Biozzi et
al., 1956), and both dextran sulphate
(Diamantstein et al., 1971; Bradfield,
Souhami and Addison, 1974) and diethyl-
aminoethyl (DEAE)-dextran (Wittman,
1970; Houston et al., 1976) are adjuvants.
Dextran, DEAE-dextran and dextran
sulphate also have anti-tumour effects
(Ebbesen, 1974).
Two mechanisms of anti-tumour resist-
ance caused by CP have been distin-
guished: (1) The first follows systemic
injection of CP and is not abolished by
immunosuppressive procedures such as
T-cell depletion (Woodruff, Dunbar and
Ghaffar, 1973; Scott, 1974b) or irradiation
(Bomford and Olivotto, 1974). It is
therefore non-specific, independent of the
host immune response to tumour-specific
transplantation antigens (TSTA) andprob-
ably mediated by cytostatic macrophages
(Olivotto and Bomford, 1974; Bomford
and Christie, 1975). (2) The s.c. injection
of CP mixed with irradiated tumour cells
generates highly-specific resistance to
tumour challenge in immunologicallyR. BOMFORD AND C. MORENO
intact mice only (Scott, 1975; Bomford,
1975) which is a promotion of specific
immunity to TSTA.
The objective of the present work was
to analyse further the mechanism of the
anti-tumour activities induced by glucans
and fructosans, using the tests of non-
specific and specific activity devised for
CP.
MATERIALS AND METHODS
C. parvum
A killed suspension of CP (Coparvax) was
provided by Wellcome Reagents Ltd, Becken-
ham, Kent.
Yeast cell walls
Commercial yeast cells (Saccharomyces
cerevisiae) were washed several times with
distilled water, fixed with a 4% v/v solution
of formaldehyde in water, and washed with
water, methanol, acetone, ether and benzene,
and dried. The material was not chemically
characterized.
Glucans
Lentinan.-Lentinan is a /(1-3) glucan of
molecular weight about 106, obtained from
the mushroom Lentinus edodes (Berk.) Sing.
(Chihara et al., 1970). Batch 725, prepared
by Dr J. Hamuro, Ajinomoto Central
Research Laboratories, Kawasaki, Japan,
was kindly provided by Dr D. W. Dresser,
National Institute for Medical Research, Mill
Hill.
Pseudonigeran.-This a(1-3) glucan was
extracted from Aspergillus niger by the
method of Johnston (1965). It was insoluble
in water, yielded oligosaccharides of the
nigerose series after acid hydrolysis, and
contained less than 0 2% nitrogen.
Dextran.-Dextran, an c(1-6) glucan,
DEAE-dextran and dextran sulphate (of
mol. wts 0*5, 2-0 and 0 5 x 106 respectively)
were purchased from Pharmacia, Uppsala,
Sweden.
Fructosans
Levan.-Levan, a /(2-6) and /3(2-1) linked
polymer of fructose, was prepared from
Corynebacterium levaniformis and charac-
terized as previously described (Moreno,
Courtenay and Howard, 1976). It was soluble
in water, with an average mol. wt of about
2 x 107. Carboxymethyl-levan (CM-levan)
was prepared by direct coupling with chloro-
acetate (Inman, 1975). The degree of substi-
tution was about 16 carboxyl groups per
100 fructosyl residues.
Mice
CBA T6T6 males aged 8-12 weeks were
used.
Testsfor anti-tumour activity
Macrophage cytostasis.-At various times
after either i.v. or i.p. injection of 0-2 ml of
CP or polysaccharides in saline, peritoneal
cells were harvested and monolayers of
macrophages tested for inhibition of RI
leukaemia cell DNA synthesis as previously
described (Olivotto and Bomford, 1974).
Peritoneal cell suspensions were adjusted to
2 x 106 cells/ml, and 2 ml were placed in
30-mm Sterilin plastic Petri dishes in Dul-
becco's modification of Eagle's medium with
10% foetal calf serum. After 2 h incubation
at 37°C in a CO2 incubator, the non-adherent
cells were removed by vigorous and repeated
pipetting andwashing, and 2 ml fresh medium
was added. The number of cells remaining
attached to one dish from each group was
counted, using agrideyepiece withaninverted
microscope. It was usually about 2 x 105
cells. Dishes with macrophages from treated
mice were discarded if the total of macro-
phages was not within the range +15% of
the total of normal macrophages.
105 syngeneic RI leukaemia cells in 0-2 ml
Dulbecco's medium were added to the macro-
phage cultures, which were pulsed (for 1 h)
with [3H]TdR 16 h later, as previously
described (Olivotto and Bomford, 1974).
Cultures containing macrophages alone incor-
porated negligible amounts of [3H]TdR.
Lung nodule inhibition.-Mice treated with
CP or polysaccharides as above were injected
i.v. with 2 x 104 T3 fibrosarcoma cells, and
lung nodules counted 14 days later (Bomford
and Olivotto, 1974).
Potentiation of specific immunity.-5 x 105
irradiated (10,OOOR from a 137Cs source) M4
methylcholanthrene-induced CBA fibro-
sarcoma cells (Bomford, 1975) in 0-05 ml
saline, alone or admixed with CP or poly-
saccharides, were injected s.c. into a hind
footpad. Seven days later, 105 living M4 cells
were injected into the contralateral footpad.
Tumour growth was monitored by measuring
footpad thickness with a dial gauge caliper
42ANTI-TUMOUR EFFECT OF POLYSACCHARIDES
(Schnelltaster, H.C. Kroplin GmbH, Hessen,
West Germany). Experiments were termi-
nated 30 days after injection of the living
cells. Mice whose footpad thickness had
reached > 3 mm were considered to have
developed tumours, since at this size progres-
sion was inevitable.
Statistics
The significance ofdifferences in mean foot-
pad thickness between groups of mice, and
of mean incorporation of [3H]TdR in the
cytostasis test was assessed by Studeint's t
test, and of differences in lung nodule
numbers by the Mann-Whitney U test. In
each case significance corresponded to
P < 0.05.
RESULTS
Splenomegaly, cytostatic macrophages and
lung nodule inhibition
CP was injected 5 to 14 days before
measurement of spleen weight, testing the
cytostatic activity of macrophages, or
i.v. injection of tumour cells for lung
nodule inhibition. These times were chosen
because both tumour cell cytostasis and
lung nodule inhibition are maximal 5 days
after the i.v. injection of 350 ,tg of CP
(Olivotto and Bomford, 1974; Bomford
and Olivotto, 1974). Splenomegaly is
maximal about 14 days after i.v. injection
of a wide range of doses of CP (Adlam and
Scott, 1973).
Table I shows the effect ofi.v. injection
of 350, 200 or 100 ,tg of CP or 350 ,g
carbohydrates on spleen weight. Yeast
walls, lentinan and pseudonigeran all
induce significant splenomegaly, although
this does not attain the level of even
100 ,ug CP at 14 days. Of the dextrans,
only the polyanion dextran sulphate
produced a significant effect, and the
levans were inactive.
Yeast cell walls, lentinan and pseudo-
nigeran also induced the appearance of
cytostatic macrophages at Day 5, and
at Day 14 also, with the exception ofyeast
cell walls (Fig. 1). In the case of the
dextrans and levans, cytostatic macro-
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TABLE 1.-Spleen Index (Weight ofTreated
Spleen/Weight of Control Spleen) after
i.v. Injection of C. parvum or Polysac-
charides
Material
CP
Yeast cell walls
Lentinan
Pseudonigeran
Dextran
DEAE-dextran
Dextran sulphate
Levan
CM-levan
* Indicates P < 0.05.
Amount
injected
(KLg)
350
200
100
350
350
350
350
350
350
350
350
1
Days after
injection
.
5
2-51*
ND
ND
2-15*
1 -45*
1.51*
0-84
0-86
1- 28*
0-91
1.03
14
7 - 06*
4-65*
2-56*
1-39*
1.51*
2.09*
1 -06
1 09
1-26*
1 00
0-91
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FiG. 1.-[3H]TdR incorporation of RI
leukaemia cells growing alone, or on
monolayers of normal peritoneal macro-
phages, or of macrophages from mice
injected i.v. with 350 ,Ag of CP or glucans
5 or 14 days previously.
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phages were only obtained from mice
injected i.p. rather than i.v. (Table II).
At Day 5, both DEAE-dextran and
dextran sulphate were more active than
neutral dextran. In all these experiments,
the polysaccharides were consistently less
active than CP.
TABLE II.-Percentage Inhibition of RI
Leukaemia Cell DNA Synthesis by
Monolayers of Peritoneal Macrophages
from Mice Injected with Dextrans or
Levans
Material
oP
Dextran
DEAE-dextran
Dextran sulphate
Levan
CM-levan
CP
Dextran
DEAE-dextran
Dextran sulphate
Dose
(KLg)
400
400
400
400
800
400
800
400
350
350
350
350
Route of
Days injection
after r-
A
injection i.v. i.p.
5 99* 98*
0 33*
0 77*
0 80*
7 ND
0 69*
25 ND
1 68*
14 99* 99*
15 69*
0 62*
0 79*
* Indicates P < 0 05, compared to normal macro-
phage control. ND=Not done.
The number of lung nodules developing
after i.v. injection of 350 ,ug of CP or 1-3
glucans is shown in Fig. 2. At Day 5
lentinan and yeast cell walls caused
significant inhibition, and at Day 14 only
pseudonigeran did so.
A temporal correlation between cyto-
stasis by peritoneal macrophages and
lung nodule inhibition is apparent when
the data from Figs. 1 and 2 are presented
together as percentage inhibition of leu-
kaemia cell DNA synthesis or of lung
nodules (Fig. 3).
No lung nodule inhibition was observed
after i.v. or i.p. injection of 350 ,g of the
dextrans (data not shown).
Specific anti-tumour immunity
Mice were injected s.c. in the footpad
with 5 x 105 irradiated M4 tumour celis
alone, or admixed with 1, 10, or 100 jug of
CP or polysaccharides. Seven days later
they were challenged with 105 living M4
140
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FIG. 2.-Number of lung nodules 14 days
after injection of 2 x 104 T3 fibrosarcoma
cells into normal mice, or mice injected
i.v. with 350 ,ug of CP or glucans 5 or 14
days previously.
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FIG. 3.-Cytostatic macrophage activity
(inhibition of RI leukaemia cell DNA
synthesis) and non-specific anti-tumour
activity (inhibition of lung nodules)
expressed as percentage inhibition to show
the temporal correlation between them.
cells in the contralateral footpad. Table III
shows the proportion of mice developing
tumours, and the size of the tumours
expressed as average footpad diameter
30 days after challenge. No protection
was conferred by irradiated M4 alone.
The addition of 1 or 10 ug (but not
100 ,ug) CP resulted in complete protec-
tion. The relative inefficacy of larger
doses ofCP in combination with irradiated
cells has been reported before (Scott,
1975; Bomford, 1975). Of the polysac-
charides studied, only 100 ,tg lentinan
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TABLE III.- Growth of 105 M4 Cells in Mice Injected 7 Days Previously with 5 x 105
Irradiated M4 Cell Alone, or Mixed with C. parvum or Polysaccharides
Footpad thickness
30 days after tumour challenge
Treatment (mm± s.e., n = 6)
Untreated controls 7 6 0* 8
Irradiated M4 cells only 6 7±0 6
+CP l tg 2-1±0-2*
10 jug 2-0±0-2*
100,ug 4-6±0-6
+lentinan 1 62g 62±0-6
l0,ug 6 4±0 5
100 jug 3.9±0.9*
mpseu(lonigeran 1 ,ug 6-2±0-6
10,ug 6-3±0-6
100 ftg 5 *5±0* 5
+dextran 1 ,ug 7-1±0-5
10,g 4-9±0-6
100,ug 5 5±0 4
4- DEAE-dextran 1 ,ug 5 3±0 7
10,ug 7 9±0 2
100 Hg 6 6±0 4
+clextran 1 ,tg 7-4±1 2
sulphate 10 ,ug 7 *0±0 8
100,g 3-8±0-6*
* Jn(licates P < 0* 05 relative to irradiated M4 only.
Mice with tumours/total
6/6
6/6
0/6
0/6
5/6
6/6
6/6
3/6
6/6
6/6
6/6
6/6
5/6
6/6
5/6
6/6
6/6
5/6
6/6
4/6
and dextran sulphate caused any signifi-
cant inhibition of tumour growth. Even
here, lentinan was not effective in a
second experiment using 100, 200 or
400 Hg mixed with 5 x 105 irradiated
cells. The results with levans were
uniformly negative and are omitted from
Table III.
DISCUSSION
The activities of the polysaccharides
studied are summarized in Table IV.
All induced cytostatic macrophages. Len-
tinan, yeast cell walls and pseudonigeran
were also active in the lung-nodule
inhibition test, which is considered to be
mediated by a non-specific mechanism
(Bomford and Olivotto, 1974). Although
there is a temporal correlation between
the presence of cytostatic macrophages in
the peritoneal cavity and lung nodule
inhibition after CP injection (Bomford
and Olivotto, 1973), evidence is still
awaited of a common effector basis for
these phenomena. The parallel between
the presence of cytostatic macrophages
and lung nodule inhibition also held for
lentinan, yeast walls and pseudonigeran
in the present study, which further
strengthens the case for suggesting a
causal relationship between them.
Only lentinan and dextran sulphate
amongst the polysaccharides displayed
even marginal adjuvant activity for TSTA.
TABLE IV. A Summary ofthe Anti-tumour
Activity of the Glucans and Fructosans
Test
Material
CP
Glucans
Yeast cell
walls
Lentinan
Pseudoni-
geran
Dextran
DEAE-
dextran
Dextran
sulphate
Fructosans
Levan
Carboxy-
methyl-
levan
Macrophage
activation
i.v. i.p. Lung Adjuvant-
injec- injec- nodule icity
tion tion inhibition TSTA
+++ ±+±+ +±++ ++±
++ ND
- + ND
++ ND
+
+
_ +
+
+
±4
_±-
+
ND: Not done.
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On the basis of the tests used in this
study, therefore, it is concluded that the
anti-tumour action induced by the poly-
saccharides is predominantly non-specific.
We consider to what extent this con-
clusion is compatible with existing know-
ledge of the anti-tumour effects of these
materials in other systems, and of their
adjuvant properties.
Previous anti-tumour studies on lenti-
nan (Chihara et al., 1969, 1970), zymosan
(Manowski et al., 1957; Bradner et al.,
1958), dextrans (Ebbesen, 1974) and
levan (Leibovici et al., 1975) were aLl
performed using the i.p. route of injection
which, from the results of this study,
might be expected to have induced
cytostatic macrophages within the peri-
toneal cavity. The studies on zymosan
and levan showed retardation of growth
of transplantable tumours inoculated s.c.
or i.p., but did not analyse its mechanism
any further.
However, the anti-tumour effect of
repeated i.p. administration of lentinan
against the s.c. growth of Sarcoma 180
in mice (Chihara et al., 1969, 1970) was
not found in neonatally thymectomized
mice (Maeda and Chihara, 1973). Although
this might suggest that in this svstem
lentinan stimulates specific immunity to
TSTA, the data on the adjuvanticity of
lentinan do not support this contention.
Multiple i.p. injections of lentinan given
after i.v. injection of sheep red blood
cells (SRBC) stimulated the humoral
response in normal, but not in T-cell-
deprived mice (Dresser and Phillips,
1974), but it seems unlikely that i.p.
lentinan would modify the humoral re-
sponse to an s.c. tumour growth. Lentinan
also failed to stimulate T-cell cytotoxicity
in an allogeneic system of the DBA/2
P815 mastocytomas in C57BL/6 mice
(Dennert and Tucker, 1973). An alter-
native explanation for the T-cell depen-
dence ofthe anti-tumour effect oflentinan
is that the simultaneous influence of
cytostatic macrophages and a normal
immune response is required, either alone
being inadequate.
The effects of multiple i.p. injections of
dextran, DEAE-dextran and dextran sul-
phate have been tested in two systems, the
spontaneous leukaemia of AKR mice,
and Rauscher leukaemia-virus-induced
leukaemias in BALB/c mice (Ebbesen,
1974). If macrophages were effective in
these systems, one might have predicted
from the present results that all three
dextrans shouldhave shown some activity.
However, in the AKR system dextran had
no effect, DEAE-dextran improved sur-
vival, and dextran sulphate accelerated
tumour development. In the BALB/c
system, dextran and DEAE-dextran pro-
longed life when treatment started at the
time of palpable spleen enlargement,
whereas only dextran and dextran sul-
phate protected when injections started
from the time of infection. Clearly factors
other than cytostatic macrophages must
be involved in these systems. It was sug-
gested that the differential effects of the
dextrans on the spread of virus or on the
humoral response to it may play a role
(Ebbesen, 1974).
Dextran sulphate (but not dextran)
injected i.v. before i.v. immunization with
SRBC potentiates the humoral response
(Diamantstein et al., 1971; Bradfield et al.,
1974). The failure of dextran sulphate to
inhibitlung nodule formation in ourstudies
is not surprising, as the mechanism does
not involve an immune response to tumour
cells (see above). Dextran sulphate poten-
tiates killer T cells in the allogeneic P815
mastocytoma system (Vachek and Kolsch,
1975), which might explain why it showed
a modest adjuvant effect for TSTA in the
present study.
CP (McBride et al., 1975), lentinan
(Okuda et al., 1972), dextran sulphate and
levan (Pryjma, Humphrey and Klaus,
1974) all share the property of activating
complement by the alternate pathway.
Subsequently a plausible common mech-
anism for the induction of cytostatic
macrophage by CP and polysaccharides
has been provided by the finding of
Schorlemmer, Davies and Allison (1976)
that activated complement components
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induce lysosomal enzyme release from
macrophages.
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